SQUAREX PHARMACEUTICAL CORP
Business Summary
Squarex Pharmaceutical Corporation is a pharmaceutical company. The Company is engaged in developing a late-clinical-stage drug to improve immune function to reduce severity and incidence of infectious disease with an initial focus on oral herpes. The Company's drug SQX770 has completed a Phase I and a Phase II placebo-controlled clinical trial. SQX770 contains the active ingredient squaric acid dibutyl ester (SADBE). The SQX770 drug is topically applied on a patient's arm, not the face or lip or a lesion. In the Phase III trials and commercially, the Company plans to dose patients once every three months.
Country of Incorporation
United States of America
Incorporation Date
2012-06-26
Business Sector
Personal & Household Products & Services
Company Address
1000 Westgate Dr, Suite 1010
Get access to the below data and more business development tools by signing up for the MENA Company Data product.
- Ownership details
- Corporate structure
- Business classification
- Officers & Directors contact details
- Full company contact details
Multiply your reach by contributing your content to LSEG
LSEG contributed content reaches tens of thousands of buy and sell side professionals around the world through an integrated suite of market intelligence and transaction platforms.NEWS ON THIS COMPANY
TOP PICKS
MOST READ
MOST WATCHED
MOST POPULAR
1.
2.
3.
4.
5.
